Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Annals of Oncology 26.6 (2015): S. 1238-1244.

Keyword
-
Krebs
Onkologie

Event
Veröffentlichung
(where)
Erlangen
(who)
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
(when)
2016
Creator
Hecht, M.
Zimmer, L.
Loquai, C.
Weishaupt, C.
Gutzmer, R.
Schuster, B.
Gleisner, S.
Schulze, B.
Goldinger, S. M.
Berking, C.
Forschner, A.
Clemens, P.
Grabenbauer, G.
Müller-Brenne, T.
Bauch, J.
Eich, H. T.
Grabbe, S.
Schadendorf, D.
Schuler, G.
Keikavoussi, P.
Semrau, S.
Fietkau, R.
Distel, L. V.
Heinzerling, L.

URN
urn:nbn:de:bvb:29-opus4-74937
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:54 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Hecht, M.
  • Zimmer, L.
  • Loquai, C.
  • Weishaupt, C.
  • Gutzmer, R.
  • Schuster, B.
  • Gleisner, S.
  • Schulze, B.
  • Goldinger, S. M.
  • Berking, C.
  • Forschner, A.
  • Clemens, P.
  • Grabenbauer, G.
  • Müller-Brenne, T.
  • Bauch, J.
  • Eich, H. T.
  • Grabbe, S.
  • Schadendorf, D.
  • Schuler, G.
  • Keikavoussi, P.
  • Semrau, S.
  • Fietkau, R.
  • Distel, L. V.
  • Heinzerling, L.
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

  • 2016

Other Objects (12)

Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients

Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients

Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells

Hochschulschrift

Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells

Autocrine and paracrine effects of BRAF inhibitor induced senescence in melanoma

Autocrine and paracrine effects of BRAF inhibitor induced senescence in melanoma

Characterization of the impact of BRAF-targeted inhibition in the melanoma microenvironment

Hochschulschrift

Characterization of the impact of BRAF-targeted inhibition in the melanoma microenvironment

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Braf, Albin

Abschnitt

Braf, Albin

HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth

HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth

Midkine in uveal melanoma: expression, mechanism and clinical relevance

Midkine in uveal melanoma: expression, mechanism and clinical relevance

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase

Related objects